MARKET

XBIT

XBIT

XBiotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.02
+0.53
+4.61%
Opening 11:44 04/06 EDT
OPEN
13.50
PREV CLOSE
11.49
HIGH
13.50
LOW
11.17
VOLUME
475.12K
TURNOVER
--
52 WEEK HIGH
26.40
52 WEEK LOW
6.76
MARKET CAP
346.81M
P/E (TTM)
1.301
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average XBIT stock price target is 28.00 with a high estimate of 28.00 and a low estimate of 28.00.

EPS

XBIT News

More
  • A Peek Into The Markets: US Stock Futures Jump; Crude Oil Falls Over 3%
  • Benzinga · 5h ago
  • Incyte details late-stage data on ruxolitinib cream for atopic dermatitis
  • seekingalpha · 15h ago
  • FDA announces initiatives for antibody blood products for COVID-19
  • seekingalpha · 2d ago
  • XBiotech up 23% after hours on convalescent plasma program for COVID-19
  • seekingalpha · 2d ago

Industry

Biotechnology & Medical Research
+3.90%
Pharmaceuticals & Medical Research
+3.16%

Hot Stocks

Symbol
Price
%Change

About XBIT

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. It focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The Company has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The Company has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. It also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS).
More

Webull offers kinds of XBiotech Inc stock information, including NASDAQ:XBIT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XBIT stock news, and many more online research tools to help you make informed decisions.